HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jung Soon Hwang Selected Research

1,1'- (4,4'- (((5- chloropyrimidine- 2,4- diyl)bis(azanediyl))bis(3- methoxy- 4,1- phenylene))bis(piperazine- 4,1- diyl))diethanone

10/2020KRCA-0008 suppresses ALK-positive anaplastic large-cell lymphoma growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jung Soon Hwang Research Topics

Disease

2Neoplasms (Cancer)
10/2020 - 11/2015
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2020
1Edema (Dropsy)
11/2018
1Inflammation (Inflammations)
11/2018
1Glioma (Gliomas)
08/2017
1Brain Diseases (Brain Disorder)
01/2016
1Ischemia
01/2016
1Colonic Neoplasms (Colon Cancer)
11/2015

Drug/Important Bio-Agent (IBA)

11,1'- (4,4'- (((5- chloropyrimidine- 2,4- diyl)bis(azanediyl))bis(3- methoxy- 4,1- phenylene))bis(piperazine- 4,1- diyl))diethanoneIBA
10/2020
1NucleophosminIBA
10/2020
1Interleukin-6 (Interleukin 6)IBA
11/2018
1PhosphoproteinsIBA
11/2018
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
08/2017
1diallyl trisulfideIBA
08/2017
1Proteins (Proteins, Gene)FDA Link
01/2016
1Antineoplastic Agents (Antineoplastics)IBA
11/2015
1SurvivinIBA
11/2015
1shogaolIBA
11/2015

Therapy/Procedure

1Therapeutics
11/2015